{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:34:15Z","timestamp":1773956055729,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41429-024-00789-1","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:55:33Z","timestamp":1731585333000},"page":"45-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structure-activity relationship studies of ME1111, a novel antifungal agent for topical treatment of onychomycosis"],"prefix":"10.1038","volume":"78","author":[{"given":"Naomi","family":"Takei-Masuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"789_CR1","first-page":"32","volume":"14","author":"AKC Leung","year":"2020","unstructured":"Leung AKC, Lam JM, Leong KF, Hon KL, Barankin B, Leung AAM, et al. Onychomycosis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14:32\u201345.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"789_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jaad.2018.03.062","volume":"80","author":"SR Lipner","year":"2019","unstructured":"Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019;80:835\u201351.","journal-title":"J Am Acad Dermatol"},{"key":"789_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1365-4362.1999.00015.x","volume":"38","author":"E Haneke","year":"1999","unstructured":"Haneke E, Roseeuw D. The scope of onychomycosis: epidemiology and clinical features. Int J Dermatol. 1999;38:7\u201312.","journal-title":"Int J Dermatol"},{"key":"789_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1067\/mjd.2000.107754","volume":"43","author":"MA Ghannoum","year":"2000","unstructured":"Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"789_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40266-021-00917-8","volume":"39","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Venkataraman M, Talukder M. Onychomycosis in older adults: prevalence, diagnosis, and management. Drugs Aging. 2022;39:191\u20138.","journal-title":"Drugs Aging"},{"key":"789_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1517\/13543784.16.2.157","volume":"16","author":"MRK Alley","year":"2007","unstructured":"Alley MRK, Baker SJ, Beutner KR, Plattner J, et al. Recent progress on the topical therapy of onychomycosis. Expert Opin Investig Drugs. 2007;16:157\u201367.","journal-title":"Expert Opin Investig Drugs"},{"key":"789_CR7","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1128\/AAC.00111-14","volume":"58","author":"K Sugiura","year":"2014","unstructured":"Sugiura K, Sugimoto N, Hosaka S, Katafuchi-Nagashima M, Arakawa Y, Tatsumi Y, et al. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment. Antimicrob Agents Cheomother. 2014;58:3837\u201342.","journal-title":"Antimicrob Agents Cheomother"},{"key":"789_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1128\/AAC.01739-15","volume":"60","author":"Y Tabata","year":"2015","unstructured":"Tabata Y, Takei-Masuda N, Kubota N, Takahata S, Ohyama M, Kaneda K, et al. Characterization of antifungal activity and nail penetration of ME1111, a new antifungal agent for topical treatment of onychomycosis. Antimicrob Agents Cheomother. 2015;60:1035\u20139.","journal-title":"Antimicrob Agents Cheomother"},{"key":"789_CR9","first-page":"e00779","volume":"62","author":"N Kubota-Ishida","year":"2017","unstructured":"Kubota-Ishida N, Takei-Masuda N, Kaneda K, Nagira Y, Chikada T, Nomoto M, et al. In vitro human onychopharmacokinetic and pharmacodynamic analyses of ME1111, a new topical agent for onychomycosis. Antimicrob Agents Chemother. 2017;62:e00779\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"789_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/03639045.2016.1201098","volume":"43","author":"X Hui","year":"2017","unstructured":"Hui X, Jung EC, Zhu H, Maibach H. Antifungal ME1111 in vitro human onychopharmacokinetics. Drug Dev Ind Pharm. 2017;43:22\u20139.","journal-title":"Drug Dev Ind Pharm"},{"key":"789_CR11","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/jps.20901","volume":"96","author":"X Hui","year":"2007","unstructured":"Hui X, Baker SJ, Wester RC, Barbadillo S, Cashmore AK, Sanders V, et al. In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate. J Pharm Sci. 2007;96:2622\u201331.","journal-title":"J Pharm Sci"},{"key":"789_CR12","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.2042-7158.1997.tb06127.x","volume":"49","author":"D Mertin","year":"1997","unstructured":"Mertin D, Lippold BC. In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: prediction of the penetration rate of antimycotics through the nail plate and their efficacy. J Pharma Pharmacol 1997;49:866\u201372.","journal-title":"J Pharma Pharmacol"},{"key":"789_CR13","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1128\/AAC.01790-15","volume":"60","author":"S Takahata","year":"2016","unstructured":"Takahata S, Kubota N, Takei-Masuda N, Yamada T, Maeda M, Alshahmi MM, et al. Mechanism of action of ME1111, a novel antifungal agent for topical treatment of onychomycosis. Antimicrob Agents Chemother. 2016;60:873\u201380.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00789-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:32:39Z","timestamp":1736137959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-024-00789-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1038\/s41429-024-00789-1","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}